8-K - Barinthus Biotherapeutics plc. - 5.02
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001104659-26-046861
Filing Date: 2026-04-22
Accepted: 2026-04-22 16:30:26
Documents: 12
Period of Report: 2026-04-22
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Barinthus Biotherapeutics plc. (Filer) CIK : 0001828185 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 26884221 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 8-K | tm2612491d1_8k.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA | vacc-20260422.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | vacc-20260422_def.xml | EX-101.DEF
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | vacc-20260422_lab.xml | EX-101.LAB